This Centessa Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 2 Initiations For Thursday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

• Chardan Capital analyst Rudy Li initiated coverage on Centessa Pharmaceuticals plc CNTA with a Buy rating and announced a price target of $30. Centessa Pharmaceuticals shares closed at $12.11 on Wednesday. See how other analysts view this stock.
• Oppenheimer analyst Andreas Argyrides initiated coverage on InflaRx N.V. IFRX with an Outperform rating and announced a price target of $6. InflaRx shares closed at $1.49 on Wednesday. See how other analysts view this stock.

Considering buying CNTA stock? Here’s what analysts think:

Get Started

Start Futures Trading Fast — with a $200 Bonus

Join Plus500 today and get up to $200 to start trading real futures. Practice with free paper trading, then jump into live markets with lightning-fast execution, low commissions, and full regulatory protection.

Get Started

Read This Next:

• How To Earn $500 A Month From McKesson Stock Ahead Of Q4 Earnings

Photo via Shutterstock